Sophia Delicou: How Does Lifelong Transfusion Therapy Affect Everyday Life of Adults with Hemoglobinopathies
Sophia Delicou, Clinical Hematologist and Head of the Thalassemia and Sickle Cell Unit at Hippocration General Hospital, Athens, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Transfusion Clinique et Biologique:
”New Publication
How does lifelong transfusion therapy affect the everyday life of adults with hemoglobinopathies?
Our newly published article, ‘Quality of life in patients with transfusion-dependent hemoglobinopathies: evidence from an Expert Center in Greece,’ highlights the real-world burden of chronic transfusion care, as reported directly by patients.
The study sheds light on key challenges such as frequent hospital visits, treatment adherence, monitoring of iron overload, and ongoing concerns about blood availability, issues that significantly shape daily life beyond clinical outcomes.
Listening to patients’ experiences is essential for developing more organized, patient-centered, and sustainable care pathways.”
Title: Quality of life in patients with transfusion-dependent hemoglobinopathies: evidence from an Expert Centre in Greece
Authors: Sophia Delicou, Aikaterini Xydaki, Maria Moraki, Natalia Karantzanou, Clive Richardson, Constantina Politis
Read the Full Article on Transfusion Clinique et Biologique
Stay updated with Hemostasis Today.
-
Feb 11, 2026, 09:13Tareq Abadl: Hematuria vs Hemoglobinuria vs Myoglobinuria
-
Feb 10, 2026, 16:52Understanding Risks Factors of Cancer-Associated Thrombosis – World Thrombosis Day
-
Feb 10, 2026, 16:50Sophia Delicou: Does Hepatic Dysfunction Truly Reflect Thrombotic Risk in Hemoglobinopathies?
-
Feb 10, 2026, 16:42Veronica Sanchez: AHA Scientific Statement on Maternal Stroke in Pregnancy and Postpartum
-
Feb 10, 2026, 16:40Arsene Mekinian: Multidisciplinary Specialties Forum on Pulmonology and Internal Medicine
-
Feb 10, 2026, 16:35Abdul Mannan: Advances in the Management of Von Willebrand Disease
-
Feb 10, 2026, 16:16Wolfgang Miesbach: How ‘Benign’ PDE Inhibitors Shape Platelet Function
-
Feb 10, 2026, 16:14Yves Bikorimana: What Every Lab and Clinician Should Know on Pseudothrombocytopenia
-
Feb 10, 2026, 16:11NTLM Webinar on Major Haemorrhage Simulations – National Blood Transfusion Committee